Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alliance Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?

To: grasshopper who wrote (257)	5/7/1998 12:08:00 PM
From: David Howe	Read Replies (2) \| Respond to of 548

San Diego Biotech Investment Fieldtrip June 2-5 Features Visits To 12 Companies Event Includes an Opening Address on HIV by a Researcher from The Salk Institute and a Scientific Panel Discussion at The Scripps Research Institute SAN MATEO, Calif., May 7 /PRNewswire/ -- The fourth annual San Diego Biotech Investment Fieldtrip will be held Tuesday, June 2 through Friday, June 5 at the San Diego Marriott La Jolla Hotel. The invitation-only event gives analysts and portfolio managers the opportunity to meet with the management and scientific staff of 16 biotechnology companies at their facilities. This year's format will feature 12 site visits at the companies and additional presentations at the hotel by four companies. The 12 companies hosting site visits include: Agouron Pharmaceuticals, Inc.; Alliance Pharmaceutical Corp.; Amylin Pharmaceuticals, Inc.; Aurora Biosciences Corporation; Corvas International, Inc.; Dura Pharmaceuticals, Inc.; Genetronics Biomedical Ltd.; IDEC Pharmaceuticals; Isis Pharmaceuticals, Inc.; La Jolla Pharmaceutical Company; Ligand Pharmaceuticals Incorporated; and Neurocrine Biosciences Inc. The companies presenting at the hotel include: Metabasis Therapeutics, Inc.; Molecular Biosystems; Sibia Neurosciences; and Trega Biosciences, Inc. The program will commence on Tuesday afternoon at the Marriott, with an address by Dr. Thomas Hope, assistant professor at The Salk Institute. He will discuss the latest research in HIV and the role of San Diego scientists in HIV research. On Friday, June 5 the program will conclude with a panel discussion at The Scripps Research Institute on the molecular structures that enable cells to adhere to biological membranes and to each other. The research panelists are David A. Cheresh, M.D., Vito Quaranta, M.D. and Sanford Jack Shattil, M.D. Sponsorship: Several event sponsors include Biospace, Dewe Rogerson, Lyon & Lyon, Raymond James, and Silicon Valley Bank. Conference Management: Conference management is being provided by Russell-Welsh, Inc., a San Mateo-based consulting firm specializing in public relations and investor relations for emerging biotechnology, pharmaceutical, medical device and drug delivery companies. SOURCE Russell-Welsh, Inc. CO: Russell-Welsh, Inc. ST: California